IXICO (LON:IXI) Share Price Passes Above 50-Day Moving Average – Should You Sell?

IXICO plc (LON:IXI)’s stock price crossed above its 50 day moving average during trading on Monday . The stock has a 50 day moving average of GBX 11.79 ($0.15) and traded as high as GBX 11.89 ($0.15). IXICO shares last traded at GBX 11.89 ($0.15), with a volume of 8 shares changing hands.

IXICO Price Performance

The company has a debt-to-equity ratio of 3.22, a quick ratio of 4.90 and a current ratio of 3.64. The company’s 50 day moving average price is GBX 11.79 and its 200-day moving average price is GBX 10.11. The company has a market cap of £5.57 million, a price-to-earnings ratio of -287.75, a PEG ratio of -0.38 and a beta of 0.86.

IXICO (LON:IXI) last posted its quarterly earnings results on Wednesday, December 4th. The company reported GBX (4.14) (($0.05)) earnings per share (EPS) for the quarter. IXICO had a negative return on equity of 16.99% and a negative net margin of 31.10%. On average, equities research analysts forecast that IXICO plc will post -289.3584879 earnings per share for the current fiscal year.

Insider Transactions at IXICO

In other news, insider Grant Nash acquired 260,000 shares of the stock in a transaction on Wednesday, December 4th. The shares were purchased at an average cost of GBX 12 ($0.15) per share, for a total transaction of £31,200 ($38,556.60). 30.28% of the stock is owned by insiders.

IXICO Company Profile

IXICO is a fast growing and profitable medical data analytics company, providing data management and advanced analytics to the pharmaceutical clinical trials market. Established in 2004 and listed as a public company in October 2013, IXICO has firmly established itself as a trusted partner to the global pharmaceutical industry developing new therapies for neurological conditions such as Alzheimer’s, Parkinson’s and Huntington’s disease.

Our purpose is to advance medicine and human health by turning data into clinically meaningful information, providing valuable new insights in neuroscience.